Scientists simulated what happens when the pipes and tunnels that divert rainwater fail. In one scenario, 30 percent of local residents couldn’t reach an E.R. By Alexander Nazaryan Culverts aren’t ...
Revolution Medicines recently made history with the approval of its RAS inhibitor Rasonque for advanced pancreatic cancer. But behind RevMed is an entire field of biotechs working to broaden the reach ...
The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one ...
The FDA approved daraxonrasib, the first targeted therapy for metastatic pancreatic adenocarcinoma, citing a survival benefit vs chemotherapy. The FDA approved daraxonrasib (Rasonque; Revolution ...
The FDA has approved the first RAS-targeted therapy for metastatic pancreatic cancer, offering a new treatment option for patients with previously treated disease. Daraxonrasib (Rasonque, Revolution ...
Solar projects impact, and are impacted by, watershed conditions extending far beyond the site. Image: Castillo. The risk of flooding to and from solar projects is a growing challenge for the PV ...
Crews closed NE 128th Way, just west of Avondale Road NE on August 17, 2026, to complete a culvert replacement project. During construction, crews identified additional drainage improvements needed ...
Unmanned Surface Vessel Division 12 (Sea Hunter) and 13 (Sea Hunter) conduct unit level training underway in San Diego Bay, California, May 1, 2025. US Navy photo The Navy’s portfolio acquisition ...
Crews hit the road this week to begin creating a database of conditions at culverts, bridges, dams, weirs and other manmade structures in Northwest Indiana streams. Their information will help the ...
UVM students help clear leaves from a culvert as part of the Culvert Crawlers program. Photo courtesy Charis Boke A tube of corrugated metal running under a road might not look like much. But when the ...
b RAS G12, G13 or Q61 mut or no RAS mut identified. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting II. This abstract does not include a full text component.